54 Stocks Moving In Thursday's Mid-Day Session

Loading...
Loading...

Gainers

  • Willamette Valley Vineyards, Inc. WVVI climbed 40.5% to $14.39.
  • Dolphin Entertainment, Inc. DLPN shares gained 23.1% to $14.14. Dolphin Entertainment recently reported better-than-expected Q4 sales results.
  • ShiftPixy, Inc. PIXY surged 22.5% to $3.075 as the company said it has been named as sponsor related to 4 SPACs.
  • JAKKS Pacific, Inc. JAKK jumped 20% to $8.80 after the company reported better-than-expected Q1 results.
  • Galera Therapeutics, Inc. GRTX gained 20% to $7.93 after the company announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo, in patients with locally advanced pancreatic cancer who are undergoing stereotactic body radiation therapy.
  • 1-800-FLOWERS.COM, Inc. FLWS rose 18.1% to $29.31 after the company reported better-than-expected Q3 results.
  • VEREIT, Inc. VER gained 17% to $48.29 after the company announced an all-stock merger agreement with Realty Income.
  • MEDIROM Healthcare Technologies Inc. MRM gained 16.5% to $10.43.
  • Ocular Therapeutix, Inc. OCUL surged 15.3% to $18.00. Ocular Therapeutix, reported multiple scientific presentations at the Association for Research in Vision and Ophthalmology Annual Meeting.
  • Atossa Therapeutics, Inc. ATOS jumped 15% to $2.53.
  • Communications Systems, Inc. JCS gained 14.6% to $6.74 as the company agreed to sell its Transition Networks and Net2Edge businesses to Lantronix.
  • Realogy Holdings Corp. RLGY surged 14% to $17.39 following upbeat quarterly results.
  • Vaxart, Inc. VXRT gained 13% to $9.52 as the company said its founder and chief scientific officer, Sean Tucker, Ph.D., will present at the World Vaccine Congress Washington that will be held virtually from May 4-6, 2021.
  • AtriCure, Inc. ATRC surged 12.5% to $78.56 after the company reported that its EPi-Sense System was approved by the FDA for treatment of long-standing persistent afib patients.
  • Capricor Therapeutics, Inc. CAPR shares climbed 11.9% to $4.42 after the company signed exclusive worldwide license agreement with Johns Hopkins University to include engineered exosomes for vaccines and therapeutics as part of the company's exosome technology portfolio.
  • Extreme Networks, Inc. EXTR surged 10.5% to $11.81. The company recently reported better-than-expected Q3 results.
  • Alliance Data Systems Corporation ADS gained 10.4% to $119.07 following upbeat Q1 results.
  • Nokia Corporation NOK shares climbed 10.2% to $4.63 after reporting upbeat Q1 results.
  • Bloomin' Brands, Inc. BLMN gained 9.3% to $31.48 after the company reported better-than-expected Q1 results.
  • MRC Global Inc. MRC surged 8.8% to $9.86. The company recently released Q1 results.
  • Cheesecake Factory Inc CAKE rose 6.3% to $62.69 after reporting higher quarterly earnings.
  • Facebook, Inc. FB rose 6% to $325.49 after the company reported upbeat results for its first quarter on Wednesday. The company reported 1.88 billion daily active users, up 8% year-over-year, as well as 2.85 billion monthly active users, up 10% year-over-year.
  • QUALCOMM Incorporated QCOM rose 4% to $142.03 after the company reported better-than-expected Q2 results and issued strong Q3 EPS guidance.

Check out these big penny stock gainers and losers


Losers

  • Adverum Biotechnologies, Inc. ADVM shares dipped 60.4% to $4.0250 after the company announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
  • Farmmi, Inc. FAMI fell 56.3% to $0.3455 after the company priced its $42.0 million upsized underwritten public offering of ordinary shares.
  • Cara Therapeutics, Inc. CARA fell 46% to $13.94 after the company announced mixed topline results from its KARE Phase 2 dose-ranging clinical trial of oral Korsuva for the treatment of moderate-to-severe pruritus in mild-to-severe atopic dermatitis patients. The company said the study did not meet the primary endpoint of worst-itch NRS change from baseline at week 12 or secondary endpoint of 4-point responder analysis in the intent-to-treat patient population. However, the study achieved primary endpoint of worst-itch NRS change and secondary endpoint of 4-point responder analysis in pre-specified analyses of mild-to-moderate AD patients, comprising 64% of ITT population.
  • Atomera Incorporated ATOM fell 25.6% to $16.51 after the company reported Q1 earnings results.
  • Brooklyn ImmunoTherapeutics, Inc. BTX dipped 24.8% to $32.86. Brooklyn ImmunoTherapeutics acquired license for mRNA technology platform of Factor Bioscience Limited And Novellus Therapeutics Limited.
  • Impinj, Inc. PI dropped 20.6% to $46.10 after reporting a decline in quarterly earnings.
  • Palisade Bio, Inc. PALI fell 19.9% to $8.22.
  • Tiptree Inc. TIPT fell 19.5% to $10.10 after the company reported it has decided to withdraw the registration statement relating to previously announced IPO by Fortegra due to ‘prevailing market conditions and the high value.’
  • Brightcove Inc. BCOV dropped 19.3% to $15.69 after the company issued Q2 EPS and sales guidance below estimates.
  • FormFactor, Inc. FORM fell 19% to $38.73 after the company reported worse-than-expected Q1 EPS results.
  • Selecta Biosciences, Inc. SELB dipped 18.3% to $3.175. Based on an internal strategic review and prioritization of its portfolio, Asklepios BioPharmaceutical Inc (AskBio) has decided to give all rights of methylmalonic acidemia (MMA) to Selecta Biosciences.
  • Galectin Therapeutics Inc. GALT shares fell 17% to $4.2350 after jumping over 22% on Wednesday. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company's galectin-3 inhibitor, belapectin.
  • Vyant Bio, Inc. VYNT fell 16.7% to $3.8750 after climbing 16% on Wednesday. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to 'design and qualify biomarker-specific small protein therapeutics.'
  • MicroVision, Inc. MVIS dipped 15.7% to $17.69.
  • 22nd Century Group, Inc. XXII fell 15.6% to $4.7201.
  • Peabody Energy Corporation BTU dropped 15.3% to $3.6301 following quarterly results.
  • Cohu, Inc. COHU dipped 14.2% to $40.15 after reporting Q1 results.
  • Resolute Forest Products Inc. RFP dropped 13.8% to $13.40 after reporting preliminary Q1 results.
  • Cree, Inc. CREE fell 13.6% to $97.31 after the company issued Q4 EPS guidance below analyst estimates. JP Morgan also downgraded the stock from Neutral to Underweight.
  • Ribbon Communications Inc. RBBN dipped 13.5% to $7.03 following weak quarterly sales.
  • Nemaura Medical Inc. NMRD dipped 12.6% to $4.73.
  • eBay Inc. EBAY fell 11% to $55.47. eBay reported upbeat Q1 earnings, but issued weak earnings guidance for the current quarter.
  • Teladoc Health, Inc. TDOC fell 9.8% to $168.03 after reporting Q1 results.
  • Ford Motor Company F fell 9.6% to $11.23 after the company reported Q1 earnings results.
  • Citrix Systems, Inc. CTXS dropped 9.4% to $125.49 after the company reported worse-than-expected Q1 results.
  • Lyft, Inc. LYFT fell 8.5% to $57.96 on reports the US Labor Secretary said most US gig workers should be classified as employees.
  • ServiceNow, Inc. NOW fell 8% to $512.87 after the company reported Q1 earnings results.
  • Tenaris S.A. TS fell 7.9% to $20.86 after the company reported Q1 results.
  • American Shared Hospital Services AMS dropped 7.9% to $2.4498.
  • Hologic, Inc. HOLX fell 7.3% to $67.11 after the company reported worse-than-expected Q2 results and issued weak Q3 guidance.
  • Ashford Hospitality Trust, Inc. AHT fell 7.2% to $2.31 after surging around 32% on Wednesday.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasElectronic Equipment ManufacturersInformation TechnologyMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...